Suivi de l'adhésion thérapeutique des patients hypertendus ou dyslipi- démiques par les cercles de qualité médecins-pharmaciens [Monitoring drug adherence for hypertensive and dyslipidemic patients in networks of community-based pharmacists and physicians].

Détails

Ressource 1Télécharger: RMS_idPAS_D_ISBN_pu2008-32s_sa06_art06.pdf (470.10 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_18AE6A6FCBB1
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Suivi de l'adhésion thérapeutique des patients hypertendus ou dyslipi- démiques par les cercles de qualité médecins-pharmaciens [Monitoring drug adherence for hypertensive and dyslipidemic patients in networks of community-based pharmacists and physicians].
Périodique
Revue Médicale Suisse
Auteur⸱e⸱s
Santschi V., Rodondi N., Bugnon O., Pannatier A., Burnier M.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
2008
Peer-reviewed
Oui
Volume
4
Numéro
170
Pages
1928-1936
Langue
français
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Résumé
Patient adherence is often poor for hypertension and dyslipidaemia. A monitoring of drug adherence might improve these risk factors control, but little is known in ambulatory care. We conducted a randomised controlled study in networks of community-based pharmacists and physicians in the canton of Fribourg to examine whether monitoring drug adherence with an electronic monitor (MEMS) would improve risk factor control among treated, but uncontrolled hypertensive and dyslipidemic patients. The results indicate that MEMS achieve a better blood pressure control and lipid profile, although its implementation requires considerable resources. The study also shows the value of collaboration between physicians and pharmacists in the field of patient adherence to improve ambulatory care of patients with cardiovascular risk factors.
Mots-clé
Anticholesteremic Agents/therapeutic use, Antihypertensive Agents/therapeutic use, Cholesterol/blood, Cholesterol, HDL/blood, Diastole/drug effects, Dyslipidemias/drug therapy, Humans, Hypercholesterolemia/drug therapy, Hypertension/drug therapy, Hypolipidemic Agents/therapeutic use, Monitoring, Physiologic/methods, Patient Compliance, Pharmacists, Physicians, Systole/drug effects
Pubmed
Création de la notice
29/01/2009 22:14
Dernière modification de la notice
27/08/2024 6:21
Données d'usage